Subscribe

Getting Your Life Sciences Transaction Done in the Current Competition Law Environment

Getting Your Life Sciences Transaction Done in the Current Competition Law Environment

  • Wednesday, March 6, 2024 11:00 AM - 12:00 PM EST

Global antitrust enforcement authorities have combined aggressive rhetoric with policy statements and procedural changes to take targeted enforcement action against reportable transactions, with a stated focus and heightened level of scrutiny directed at the life sciences industry. In fact, U.S. antitrust agencies have expressed an intent to "work hand-in-hand with international and domestic enforcement partners to take an aggressive approach to tackling anticompetitive pharmaceutical mergers."

Amidst a growing regime of global filings, the U.S. agencies have finalized significant changes to their merger guidelines and proposed extensive revisions to the filing requirements that parties under the Hart-Scott Rodino Act must satisfy. In Europe, life sciences deals face heavy scrutiny by antitrust regulators, in addition to new or expanded obligations under the E.U. Foreign Subsidies Regulation and Foreign Direct Investment rules. In combination, this heightened global enforcement landscape raises new complexities for a wide range of life sciences transactions.

Please join our transatlantic panel on Wednesday, March 6, at 11:00 a.m. (EDT) as they discuss current enforcement trends in the U.S., E.U., and U.K., and discuss global merger control issues regarding deal timing in light of the significantly more burdensome HSR filing requirements under consideration, the burden and expense of regulatory compliance and how to address that in transaction documents, and the coordination of cross-jurisdiction merger review processes. Facilitated by two of Covington’s Corporate partners J. D. Weinberg and Lauren Rakitin, the conversation will feature three of Covington's leading Antitrust practitioners in the life sciences industry, James Dean, Sibel Yilmaz, and James Marshall, who will offer strategic insights for life sciences companies contemplating acquisitions, strategic collaborations, and licensing agreements in this increasingly challenging environment.

Event Details

Wednesday, March 6, 2024
11 a.m. - 12 p.m EST
8 - 9 a.m. PST
5 - 6 p.m. CET
4 - 5 p.m. GMT

Log-in details will be provided upon registration.

Click here to register.

This event is closed to the press.

CLE Credit: Covington & Burling LLP is certified by the State Bar of California and the New York State Continuing Legal Education Board as an Accredited Provider of Continuing Legal Education (CLE) credit. In accordance with jurisdictional requirements, pertinent participants may anticipate claiming a maximum of 1.0 CLE credit hours in NY and CA upon verification of their attendance. Universal Certificates of Attendance will be provided to all attendees should you wish to self-report in another jurisdiction.

Presenters

James Dean, Partner
jdean@cov.com

Sibel Yilmaz, Partner
syilmaz@cov.com

James Marshall, Partner
jmarshall@cov.com

J. D. Weinberg, Partner
jweinberg@cov.com

Lauren Rakitin, Partner
lrakitin@cov.com